Search In this Thesis
   Search In this Thesis  
العنوان
The Association between Silent Mating Type Information Regulator 2 Homolog 1 (SIRT1) Gene Polymorphism and Systemic Lupus Erythematosus (SLE)/
الناشر
Ain Shams University.
المؤلف
Ismail,Sarah Abdel Mohsen Abdel Sadek .
هيئة الاعداد
باحث / ساره عبد المحسن عبد الصادق اسماعيل
مشرف / عبير ابراهيم عبد المجيد
مشرف / منال محسن محمد كمال الدين
مشرف / نشوي علي مرشدي
مشرف / ولاء احمد يسرى محمد قابيل
تاريخ النشر
2021
عدد الصفحات
125.p;
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الطب (متفرقات)
تاريخ الإجازة
1/1/2021
مكان الإجازة
جامعة عين شمس - كلية الطب - Clinical Pathology
الفهرس
Only 14 pages are availabe for public view

from 125

from 125

Abstract

Systemic lupus erythematosus (SLE) is a chronic severe multisystem autoimmune disease that affects multiple organs being characterized by heterogeneous manifestations that may affect the skin, joint, heart, brain, kidney, hematopoietic and central nervous systems. It is characterized by autoantibody production for a variety of self-antigens, but it is specifically associated with anti-double stranded DNA (anti-dsDNA), and immune complex deposition.
The Lupus Foundation of America estimates that 1.5 million Americans, and at least five million people worldwide, have a form of lupus.
The SIRT1 is a member of sirtuin family of histone deacetylase enzymes that has been implicated in a variety of physiologic and pathologic events, including energy metabolism, inflammation, cell survival, and age-related alterations.
On the light of the previous data, the present study was conducted to investigate the association of SIRT1 rs3758391 gene polymorphism with SLE and to study its impact on disease progression to lupus nephritis.
This was a case control study, conducted in the Clinical Pathology Department, Ain Shams University Hospitals in the period between December 2018 till September 2019. The study included 50 individuals attending the outpatient clinics and inpatient ward of Rheumatology Department of Ain Shams University Hospitals. Subjects enrolled in the study were classified into two groups: group I included 34 SLE patients and group II included 16 control subjects